Bill Sponsor
Senate Bill 4769
116th Congress(2019-2020)
Maternal Health Pandemic Response Act of 2020
Introduced
Introduced
Introduced in Senate on Sep 30, 2020
Overview
Text
Introduced
Sep 30, 2020
Latest Action
Sep 30, 2020
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
4769
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Democrat
Massachusetts
Democrat
California
Democrat
Minnesota
Democrat
New Jersey
Senate Votes (0)
House Votes (0)
No Senate votes have been held for this bill.
Summary

Maternal Health Pandemic Response Act of 2020

This bill addresses maternal health during the COVID-19 (i.e., coronavirus disease 2019) emergency by supporting data collection, development of COVID-19 therapeutics and workplace protections, and other activities.

Specifically, the Department of Health and Human Services must issue guidance for states and local health departments on collecting data on pregnancy and postpartum status in conjunction with COVID-19 tests. In addition, the bill provides funds for the Centers for Disease Control and Prevention (CDC) to expand particular maternal health surveillance programs. The CDC and the Centers for Medicare & Medicaid Services must also publish pregnancy and postpartum data related to COVID-19, and the CDC and the Indian Health Service must consult with tribes about collecting this data for tribal populations.

Additionally, the National Institutes of Health (NIH) and the Food and Drug Administration must collect information about the effects of COVID-19 therapeutics on pregnant and postpartum individuals. The NIH must also ensure that at least one vaccine will be suitable for that population and must support related research.

In addition, the Department of Labor must implement an emergency temporary standard to protect employees from workplace exposures to the virus that causes COVID-19 that specifically addresses pregnant and postpartum individuals. Certain regulatory requirements shall not apply in developing this standard.

The CDC must also carry out an education campaign about pregnancy and COVID-19 and must establish a task force that addresses maternity care during the COVID-19 emergency.

Furthermore, the Government Accountability Office must report on maternal health and public health emergency preparedness.

Text (1)
September 30, 2020
Actions (2)
09/30/2020
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
09/30/2020
Introduced in Senate
Public Record
Record Updated
Jan 11, 2023 1:44:39 PM